AST (Aspartate Aminotransferase) Normal Range and Interpretation
The normal range for AST is 29-33 IU/L for men and 19-25 IU/L for women, though most commercial laboratories use higher upper limits of normal (ULN) around 40-45 IU/L 1, 2. Elevations should be classified as mild (<5× ULN), moderate (5-10× ULN), or severe (>10× ULN) 1.
Normal Reference Values
The true healthy normal AST levels are significantly lower than what most commercial laboratories report:
- Men: 29-33 IU/L (0.48-0.55 μkat/L)
- Women: 19-25 IU/L (0.32-0.42 μkat/L) 1
However, most clinical laboratories use approximately 40-45 IU/L as the ULN 3, 2. Even values within the "normal" range of 20-39 IU/L carry increased risk for liver-related mortality 4. Specifically, AST levels of 20-29 IU/L confer a 2.5-fold increased risk in men and 3.3-fold in women, while levels of 30-39 IU/L increase risk 8-fold in men and 18-fold in women compared to levels <20 IU/L 4.
Interpretation of Elevated AST Levels
Mild Elevation (<5× ULN or <200-225 IU/L)
This pattern suggests chronic hepatocellular injury from common causes: nonalcoholic fatty liver disease (NAFLD), alcoholic liver disease, chronic viral hepatitis, or medication effects 1, 5. The initial workup should include:
- Metabolic syndrome assessment (waist circumference, blood pressure, fasting lipids, glucose/A1C)
- Complete blood count with platelets
- Hepatitis B surface antigen and hepatitis C antibody
- Iron studies (serum iron, total iron-binding capacity, ferritin)
- Serum albumin 5, 6
Moderate to Severe Elevation (>5× ULN or >200-250 IU/L)
AST levels of 2-6× ULN are typical for severe alcoholic hepatitis 7. AST >500 IU/L is uncommon in alcoholic hepatitis and should prompt investigation for alternative diagnoses such as acute viral hepatitis, drug-induced liver injury, ischemic hepatitis, or acetaminophen toxicity 7.
Critical Diagnostic Patterns
AST/ALT Ratio
The AST/ALT ratio provides crucial diagnostic information:
- Ratio <1: Suggests nonalcoholic steatohepatitis (NASH), with mean ratio of 0.9 8
- Ratio >2: Suggests alcoholic liver disease (70% of cases) 7
- Ratio ≥3: Highly suggestive of alcoholic liver disease 7
In NASH patients, the AST/ALT ratio increases with fibrosis progression: 0.7 with no fibrosis, 0.9 with mild fibrosis, and 1.4 with cirrhosis 8.
AST Specificity Considerations
AST is less liver-specific than ALT because it is also present in heart, skeletal muscle, kidneys, brain, and red blood cells 1. When AST is elevated disproportionately to ALT, consider:
- Cardiac injury (myocardial infarction)
- Skeletal muscle disorders (rhabdomyolysis, polymyositis)
- Hemolysis
- Macro-AST (AST bound to immunoglobulins causing persistent elevation) 9
When to Act on AST Elevation
Hepatocellular Pattern (AST and ALT elevated disproportionately to alkaline phosphatase)
For patients with normal baseline AST:
- AST ≥5× ULN: Repeat testing in 2-5 days, evaluate for other etiologies 3
- AST ≥8× ULN: Interrupt potential causative drugs, initiate close monitoring and workup 3
- AST ≥3× ULN with total bilirubin ≥2× ULN: Interrupt drugs immediately (Hy's Law criteria for severe drug-induced liver injury) 3
For patients with elevated baseline AST:
- AST ≥3× baseline or ≥300 IU/L: Repeat testing and evaluate 3
- AST ≥5× baseline or ≥500 IU/L: Interrupt drugs and initiate workup 3
Autoimmune Hepatitis Context
AIH should be suspected with any degree of AST elevation of unknown etiology, particularly with elevated IgG and autoantibodies 10. The extent of aminotransferase elevation in AIH is highly variable, ranging from slight increases to >50× ULN 10. In AIH-related cirrhosis, AST may be normal or only mildly elevated 10.
Common Pitfalls
Relying on commercial laboratory "normal" ranges: These often miss early liver disease. Use the lower, evidence-based thresholds (men: 31 IU/L, women: 19-25 IU/L) 2, 4.
Ignoring isolated AST elevation: While less specific than ALT, persistent AST elevation warrants investigation for extrahepatic sources (cardiac, muscle, hemolysis) or macro-AST 1, 9.
Assuming normal AST excludes liver disease: In cirrhosis and advanced fibrosis, AST may be normal or only mildly elevated 10, 11.
Not establishing proper baseline: In patients with fluctuating liver disease (e.g., NASH), obtain at least two measurements 2 weeks apart and use the average as baseline 3.
Overlooking the AST/ALT ratio: This simple calculation provides powerful diagnostic information distinguishing alcoholic from nonalcoholic liver disease 7, 8.